At a cool $1B-plus in upfront, equity and early-stage cash, Regeneron ties a blockbuster R&D partnership knot with RNAi leader Alnylam →
- Forums
- ASX - By Stock
- Alnylam Deal
At a cool $1B-plus in upfront, equity and early-stage cash,...
-
- There are more pages in this discussion • 16 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)